Investing.com - TherapeuticsMD reported on Monday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
TherapeuticsMD announced earnings per share of $-3.1300 on revenue of $20.9M. Analysts polled by Investing.com anticipated EPS of $-2.0400 on revenue of $30.2M.
TherapeuticsMD shares are down 63% from the beginning of the year and are trading at $6.4600 , down-from-52-week-high.
TherapeuticsMD follows other major Healthcare sector earnings this month
TherapeuticsMD's report follows an earnings beat by J&J on October 18, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on November 1 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar